348 related articles for article (PubMed ID: 17368668)
41. Probing the ultra-high resolution structure of aldose reductase with molecular modelling and noncovalent mass spectrometry.
Darmanin C; Chevreux G; Potier N; Van Dorsselaer A; Hazemann I; Podjarny A; El-Kabbani O
Bioorg Med Chem; 2004 Jul; 12(14):3797-806. PubMed ID: 15210146
[TBL] [Abstract][Full Text] [Related]
42. Identification of structural-kinetic and structural-thermodynamic relationships for thrombin inhibitors.
Winquist J; Geschwindner S; Xue Y; Gustavsson L; Musil D; Deinum J; Danielson UH
Biochemistry; 2013 Jan; 52(4):613-26. PubMed ID: 23290007
[TBL] [Abstract][Full Text] [Related]
43. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
44. Aldose and aldehyde reductases: structure-function studies on the coenzyme and inhibitor-binding sites.
El-Kabbani O; Old SE; Ginell SL; Carper DA
Mol Vis; 1999 Sep; 5():20. PubMed ID: 10493777
[TBL] [Abstract][Full Text] [Related]
45. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
[TBL] [Abstract][Full Text] [Related]
46. Non-additivity of functional group contributions in protein-ligand binding: a comprehensive study by crystallography and isothermal titration calorimetry.
Baum B; Muley L; Smolinski M; Heine A; Hangauer D; Klebe G
J Mol Biol; 2010 Apr; 397(4):1042-54. PubMed ID: 20156458
[TBL] [Abstract][Full Text] [Related]
47. Radiation damage reveals promising interaction position.
Koch C; Heine A; Klebe G
J Synchrotron Radiat; 2011 Sep; 18(Pt 5):782-9. PubMed ID: 21862860
[TBL] [Abstract][Full Text] [Related]
48. Crystal structure of a glutamate/aspartate binding protein complexed with a glutamate molecule: structural basis of ligand specificity at atomic resolution.
Hu Y; Fan CP; Fu G; Zhu D; Jin Q; Wang DC
J Mol Biol; 2008 Sep; 382(1):99-111. PubMed ID: 18640128
[TBL] [Abstract][Full Text] [Related]
49. The alrestatin double-decker: binding of two inhibitor molecules to human aldose reductase reveals a new specificity determinant.
Harrison DH; Bohren KM; Petsko GA; Ringe D; Gabbay KH
Biochemistry; 1997 Dec; 36(51):16134-40. PubMed ID: 9405046
[TBL] [Abstract][Full Text] [Related]
50. Modulation of aldose reductase inhibition by halogen bond tuning.
Fanfrlík J; Kolář M; Kamlar M; Hurný D; Ruiz FX; Cousido-Siah A; Mitschler A; Rezáč J; Munusamy E; Lepšík M; Matějíček P; Veselý J; Podjarny A; Hobza P
ACS Chem Biol; 2013 Nov; 8(11):2484-92. PubMed ID: 23988122
[TBL] [Abstract][Full Text] [Related]
51. Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B.
Huang K; Lu W; Anderson S; Laskowski M; James MN
Protein Sci; 1995 Oct; 4(10):1985-97. PubMed ID: 8535235
[TBL] [Abstract][Full Text] [Related]
52. Glycosidase inhibition: an assessment of the binding of 18 putative transition-state mimics.
Gloster TM; Meloncelli P; Stick RV; Zechel D; Vasella A; Davies GJ
J Am Chem Soc; 2007 Feb; 129(8):2345-54. PubMed ID: 17279749
[TBL] [Abstract][Full Text] [Related]
53. Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid.
Mathews II; Vanderhoff-Hanaver P; Castellino FJ; Tulinsky A
Biochemistry; 1996 Feb; 35(8):2567-76. PubMed ID: 8611560
[TBL] [Abstract][Full Text] [Related]
54. The Effect of Halogen-to-Hydrogen Bond Substitution on Human Aldose Reductase Inhibition.
Fanfrlík J; Ruiz FX; Kadlčíková A; Řezáč J; Cousido-Siah A; Mitschler A; Haldar S; Lepšík M; Kolář MH; Majer P; Podjarny AD; Hobza P
ACS Chem Biol; 2015 Jul; 10(7):1637-42. PubMed ID: 25919404
[TBL] [Abstract][Full Text] [Related]
55. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
Ruiz FX; Cousido-Siah A; Mitschler A; Farrés J; Parés X; Podjarny A
Chem Biol Interact; 2013 Feb; 202(1-3):178-85. PubMed ID: 23295227
[TBL] [Abstract][Full Text] [Related]
56. Role of inhibitor aliphatic chain in the thermodynamics of inhibitor binding to Escherichia coli enoyl-ACP reductase and the Phe203Leu mutant: a proposed mechanism for drug resistance.
Protasevich II; Brouillette CG; Snow ME; Dunham S; Rubin JR; Gogliotti R; Siegel K
Biochemistry; 2004 Oct; 43(42):13380-9. PubMed ID: 15491144
[TBL] [Abstract][Full Text] [Related]
57. Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor.
Luić M; Koellner G; Yokomatsu T; Shibuya S; Bzowska A
Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1417-24. PubMed ID: 15272165
[TBL] [Abstract][Full Text] [Related]
58. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
[TBL] [Abstract][Full Text] [Related]
59. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
[TBL] [Abstract][Full Text] [Related]
60. Discovery of new selective human aldose reductase inhibitors through virtual screening multiple binding pocket conformations.
Wang L; Gu Q; Zheng X; Ye J; Liu Z; Li J; Hu X; Hagler A; Xu J
J Chem Inf Model; 2013 Sep; 53(9):2409-22. PubMed ID: 23901876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
